(Q37780288)

23 August 2017

1 reference

title

Therapy for beta-globinopathies: a brief review and determinants for successful and safe correction (English)

1 reference

23 August 2017

Ajay Perumbeti

1

1 reference

23 August 2017

Punam Malik

series ordinal

2

1 reference

23 August 2017

language of work or name

English

0 references

publication date

1 August 2010

1 reference

Annals of the New York Academy of Sciences

23 August 2017

number of pages

9

1 reference

based on heuristic

inferred from page(s)

published in

1 reference

23 August 2017

volume

1202

1 reference

23 August 2017

page(s)

36-44

1 reference

LMO2-associated clonal T cell proliferation in two patients after gene therapy for SCID-X1

23 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.2010.05584.X

Gene therapy. Beta-thalassemia treatment succeeds, with a caveat

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.2010.05584.X

Transgenic knockout mice with exclusively human sickle hemoglobin and sickle cell disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.2010.05584.X

Correction of sickle cell disease in transgenic mouse models by gene therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.2010.05584.X

Treatment of sickle cell anemia mouse model with iPS cells generated from autologous skin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.2010.05584.X

High-level beta-globin expression and preferred intragenic integration after lentiviral transduction of human cord blood stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.2010.05584.X

10.1111/J.1749-6632.2010.05584.X

21 January 2018

Identifiers

DOI

1 reference

23 August 2017

1 reference